Secondary Injury Microglial activation, cytokines, oxidative stress, excitotoxicity and bloodbrain barrier disruption may continue after the initial event
Key molecules in this space include semaglutide, liraglutide, dulaglutide, and orlistat, developed by companies like Novo Nordisk, Eli Lilly, and Roche
Our analysis revealed 16,711 cases of subcutaneous semaglutide and 2,508 cases of oral semaglutide
Safer alternatives include optimising tirzepatide monotherapy with appropriate dose titration, structured NHS lifestyle programmes, licensed GLP-1 receptor agonists like semaglutide (Wegovy), or referral for bariatric surgery assessment
This helps lower blood sugar levels by allowing cells to absorb glucose from the bloodstream
Hachua M, Kosowski M, Ryl S, Basiak M, Okopie B